Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BCRX
CLDX
Add up to 3 more stocks
BCRX
BioCryst Pharmaceuticals, Inc.
-1.85%
$7.95-0.15Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.02B
52W Range
$6.00 - $11.31
CLDX
Celldex Therapeutics, Inc.
-4.86%
$31.00-1.59Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.06B
52W Range
$22.10 - $45.14
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | N/A | 2.89 |
| P/S Ratio | 2.15 | 18419.87 |
| P/FCF Ratio | 5.66 | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 97.8% | 100.0% |
| Operating Margin | 39.0% | -19160.0% |
| Net Margin | -40.9% | -268385.7% |
| ROE | N/A | -42.1% |
| ROA | -69.0% | -38.4% |
| ROIC | -89.7% | -45.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.32 | 11.82 |
| Quick Ratio | 2.29 | 11.82 |
| Debt/Equity | N/A | 0.01 |
| Interest Coverage | 4.32 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.